American Journal of Obstetrics & Gynecology
Volume 198, Issue 4 , Pages 404.e1-404.e6 , April 2008

Who returns for postpartum glucose screening following gestational diabetes mellitus?

Presented at the 19th annual meeting of the Society for Pediatric and Perinatal Epidemiologic Research, Seattle, WA, June 20-21, 2006.

  • Kelly J. Hunt, PhD

      Affiliations

    • Department of Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina, Charleston, SC
    • Corresponding Author InformationReprints: Kelly J. Hunt, PhD, Medical University of South Carolina, Department of Biostatistics, Bioinformatics, and Epidemiology, 135 Cannon St, Suite 302K, PO Box 250835, Charleston, SC 29425
  • ,
  • Deborah L. Conway, MD

      Affiliations

    • Department of Obstetrics and Gynecology, University of Texas Health Science Center, San Antonio, TX.

Received 11 May 2007 ,Revised 26 July 2007 ,Accepted 8 September 2007.

References 

  1. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25:1862–1868
  2. Conway DL, Langer O. Effects of new criteria for type 2 diabetes on the rate of postpartum glucose intolerance in women with gestational diabetes. Am J Obstet Gynecol. 1999;181:610–614
  3. Greenberg LR, Moore TR, Murphy H. Gestational diabetes mellitus: antenatal variables as predictors of postpartum glucose intolerance. Obstet Gynecol. 1995;86:97–101
  4. Kjos SL, Buchanan TA, Greenspoon JS, Montoro M, Bernstein GS, Mestman JH. Gestational diabetes mellitus: the prevalence of glucose intolerance and diabetes mellitus in the first two months post partum. Am J Obstet Gynecol. 1990;163(1 Pt 1):93–98
  5. Kjos SL, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA. Predicting future diabetes in Latino women with gestational diabetes (Utility of early postpartum glucose tolerance testing). Diabetes. 1995;44:586–591
  6. Metzger BE, Cho NH, Roston SM, Radvany R. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care. 1993;16:1598–1605
  7. Gestational diabetes mellitus. Diabetes Care. 2004;27(Suppl 1):S88–S90
  8. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002;359:2072–2077
  9. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403
  10. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance (The Da Qing IGT and Diabetes Study). Diabetes Care. 1997;20:537–544
  11. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–1350
  12. Gerstein HC, Yusuf S, Bosch J, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 2006;368:1096–1105
  13. Dabelea D, Knowler WC, Pettitt DJ. Effect of diabetes in pregnancy on offspring: follow-up research in the Pima Indians. J Matern Fetal Med. 2000;9:83–88
  14. Dabelea D, Pettitt DJ. Intrauterine diabetic environment confers risks for type 2 diabetes mellitus and obesity in the offspring, in addition to genetic susceptibility. J Pediatr Endocrinol Metab. 2001;14:1085–1091
  15. Russell MA, Phipps MG, Olson CL, Welch HG, Carpenter MW. Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynecol. 2006;108:1456–1462
  16. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus (The Organizing Committee). Diabetes Care. 1998;21(Suppl 2):B161–B167
  17. Report of a WHO Consultation (Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: diagnosis and classification of diabetes mellitus). Geneva: World Health Organization, Department of Noncommunicable Disease Surveillance; 1999;
  18. Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160–3167
  19. Stern MP, Mitchell BD. Diabetes in Hispanic Americans. In:  Harris MI editors. Diabetes in America. 2nd ed.. Bethesda (MD): National Institutes of Health, National Institutes of Diabetes and Digestive Kidney Diseases; 1995;p. 631–659
  20. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183–1197
  21. Dunne F, Brydon P, Smith K, Gee H. Pregnancy in women with type 2 diabetes: 12 years outcome data, 1990-2002. Diabet Med. 2003;20:734–738
  22. Towner D, Kjos SL, Leung B, et al. Congenital malformations in pregnancies complicated by NIDDM. Diabetes Care. 1995;18:1446–1451
  23. Freinkel N. Banting Lecture 1980 (Of pregnancy and progeny). Diabetes. 1980;29:1023–1035
  24. Dabelea D, Hanson RL, Bennett PH, Roumain J, Knowler WC, Pettitt DJ. Increasing prevalence of Type II diabetes in American Indian children. Diabetologia. 1998;41:904–910
  25. Silverman BL, Rizzo T, Green OC, et al. Long-term prospective evaluation of offspring of diabetic mothers. Diabetes. 1991;40(Suppl 2):121–125
  26. O’Sullivan JB, Gellis SS, Dandrow RV, Tenney BO. The potential diabetic and her treatment in pregnancy. Obstet Gynecol. 1966;27:683–689
  27. Pettitt DJ, Knowler WC, Baird HR, Bennett PH. Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians. Diabetes Care. 1980;3:458–464
  28. Pettitt DJ, Knowler WC, Bennett PH, Aleck KA, Baird HR. Obesity in offspring of diabetic Pima Indian women despite normal birth weight. Diabetes Care. 1987;10:76–80
  29. Pettitt DJ, Knowler WC. Long-term effects of the intrauterine environment, birth weight, and breast-feeding in Pima Indians. Diabetes Care. 1998;21(Suppl 2):B138–B141
  30. Pettitt DJ, Aleck KA, Baird HR, Carraher MJ, Bennett PH, Knowler WC. Congenital susceptibility to NIDDM (Role of intrauterine environment). Diabetes. 1988;37:622–628
  31. Hanson RL, Elston RC, Pettitt DJ, Bennett PH, Knowler WC. Segregation analysis of non–insulin-dependent diabetes mellitus in Pima Indians: evidence for a major-gene effect. Am J Hum Genet. 1995;57:160–170
  32. Guzman B. The Hispanic population. Washington (DC): US Department of Commerce, Economics, and Statistics Administration, US Census Bureau; 2001;
  33. Haffner SM, Mitchell BD, Pugh JA, et al. Proteinuria in Mexican Americans and non-Hispanic whites with non–insulin-dependent diabetes mellitus. Diabetes Care. 1989;12:530–536
  34. Hunt KJ, Williams K, Resendez RG, Hazuda HP, Haffner SM, Stern MP. All-cause and cardiovascular mortality among diabetic participants in the San Antonio Heart Study: Evidence against the “Hispanic Paradox.”. Diabetes Care. 2002;25:1557–1563
  35. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP, Hazuda HP. All-cause and cardiovascular mortality among Mexican-American and non-Hispanic white older participants in the San Antonio Heart Study—evidence against the “Hispanic paradox.”. Am J Epidemiol. 2003;158:1048–1057
  36. Goff DC, Nichaman MZ, Chan W, Ramsey DJ, Labarthe DR, Ortiz C. Greater incidence of hospitalized myocardial infarction among Mexican Americans than non-Hispanic whites (The Corpus Christi Heart Project, 1988-1992). Circulation. 1997;95:1433–1440
  37. Goff DC, Ramsey DJ, Labarthe DR, Nichaman MZ. Greater case-fatality after myocardial infarction among Mexican Americans and women than among non-Hispanic whites and men (The Corpus Christi Heart Project). Am J Epidemiol. 1994;139:474–483
  38. Glucose tolerance and mortality: comparison of World Health Organization and American Diabetes Association diagnostic criteria (The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of diagnostic criteria in Europe). Lancet. 1999;354:617–621
  39. Burke JP, Williams K, Gaskill SP, Hazuda HP, Haffner SM, Stern MP. Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Intern Med. 1999;159:1450–1456
  40. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes. 1987;36:523–534
  41. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults (The Third National Health and Nutrition Examination Survey, 1988-1994). Diabetes Care. 1998;21:518–524
  42. Park MK, Menard SW, Schoolfield J. Prevalence of overweight in a triethnic pediatric population of San Antonio, Texas. Int J Obes Relat Metab Disord. 2001;25:409–416

 Cite this article as: Hunt KJ, Conway DL. Who returns for postpartum glucose screening following gestational diabetes mellitus? Am J Obstet Gynecol 2008;198:404.e1-404.e6.

 This work was supported in part by American Diabetes Association Research Award 7-03-RA-118, National Institute of Diabetes and Digestive and Kidney Diseases K01 Award 1K01 DK064867, and the Texas Diabetes Institute (University Health System Community Health Initiatives).

PII: S0002-9378(07)01114-3

doi: 10.1016/j.ajog.2007.09.015

American Journal of Obstetrics & Gynecology
Volume 198, Issue 4 , Pages 404.e1-404.e6 , April 2008